Rusan Pharma launches APOSAN drug in India
Rusan Pharma has launched APOSAN -Apomorphine Hydrochloride (HCl), in India after approval from the DCG(I). The drug APOSAN is used for the treatment of motor […]
News
DRL launches Chlorthalidone tablets in US Markets
Dr Reddy’s Laboratories has launched Chlorthalidone tablets which is used to treat high blood pressure, in the US market. The drug will be made available […]
DRL makes deal to sell its API unit in Hyderabad
Dr Reddy’s Labs (DRL) has entered into a definitive agreement for the sale of Active Pharma Ingredients (API) manufacturing business unit located in Jeedimetla, Hyderabad, […]
Glenmark Pharma ties up with Seqirus
Glenmark Pharmaceuticals ties up with Seqirus (Seqirus), part of Australia-based specialty biotechnology company CSL by an exclusive licensing agreement to commercialize Ryaltris in Australia and […]
NPPA fixes drugs of 22 formulations for bacterial infections, cardiac conditions etc.,
National Pharma Pricing Authority (NPPA) has fixed the retail and ceiling prices of 22 formulations used for treatment of various ailments including HIV, bacterial infections […]
Central Government plans to facilitate e-pharmacies
Central government of India intends to make amendments in Drug and Cosmetics Act to facilitate online sales of pharmaceutical products or epharmacy. Now, e-pharmacy registration […]
Glenmark Pharma ties up with Sam Chun Dang Pharm for ophthalmic products
Glenmark Pharmaceuticals has entered into an exclusive agreement with Sam Chun Dang Pharm (SCD) of South Korea to develop, manufacture and market a portfolio of […]
Alkem Laboratories ties up with Stempeutics Research
Alkem Laboratories has tied up with Stempeutics Research, a group company of Manipal Education and Medical Group (MEMG) for OA indication. Under this agreement, Alkem […]
Torrent Pharma acquires US based Bio Pharm Inc
Torrent plans has acquired the Bio-Pharm, Inc. (BPI) – a US-based generic pharmaceuticals and OTC company, The Bio-Pharm, Inc. (BPI). Was established in 1992 and […]
Ipca Laboratories acquires Pisgah Labs Inc, USA
Ipca Laboratories have acquired the US-based Pisgah Labs Inc for $9.65 million. Pisgah is a contract manufacturer and developer of active pharmaceutical ingredients (APls) and […]